CClinicalTrials.gg
CompletedNCT00829517Updated Feb 17, 2012

Computer-Assisted Provision of Reproductive Health Care

An interventional study of computer-assisted provision of hormonal contraception and STI module in Contraception and Sexually Transmitted Diseases, sponsored by University of Pittsburgh. Completed at 2 sites in United States. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2012-02-17.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
814
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study will be a randomized controlled trial which will evaluate the use of a computer kiosk module to compare the proportion of women of reproductive age who receive a prescription for hormonal contraception when computer-assisted provision of hormonal contraception is offered (intervention) to encounters when the study clinic provides standard contraceptive care (control). Subjects will be contacted approximately 3 months (range 2-4 months) after the clinic visit to complete a follow-up phone interview. The study population will include English and Spanish-speaking women ages 18-45 who seek care at this clinic. Our hypothesis is that computer-assisted provision of hormonal contraception (intervention)will increase the proportion of women of reproductive age who receive a prescription for hormonal contraception versus standard contraceptive care(control).

Read the detailed description

Data collection has been completed

02

Conditions studied

  • Contraception
  • Sexually Transmitted Diseases

Keywords

  • Contraception
  • sexually transmitted diseases
03

In context

Sexually Transmitted Diseases

424 studies on the registry are indexed under Sexually Transmitted Diseases; 71 are open to participants now.

This study's enrollment of 814 is above the median of 470 across 346 interventional studies indexed under Sexually Transmitted Diseases.

Browse Sexually Transmitted Diseases studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • women who speak English or Spanish who visit a study clinic

Exclusion criteria

Exclusion Criteria:

  • women who do not speak English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
814 participants (actual)

Study arms

  • Active comparator
    STI kiosk

    computer-assisted provision of screening for chlamydia

    Other: STI module

  • Experimental
    contraceptive kiosk

    computer-assisted provision of hormonal contraception

    Other: computer-assisted provision of hormonal contraception

Interventions

  • Othercomputer-assisted provision of hormonal contraception

    a computer program available at a kiosk will offer women information about and a prescription for hormonal contraception that they can ask their clinician to sign.

    Also known as: Family planning kiosk

  • OtherSTI module

    computer module available at a kiosk that will encourage women to be screened for chlamydia

    Also known as: Chlamydia kiosk

06

What researchers measure

Primary outcomes

  1. self-reported use of hormonal or more effective contraception

    Time frame: 3 months

  2. receipt of screening for sexually transmitted infection

    Time frame: 3 months

07

Study locations

2 sites
  • University of California, San Francisco
    San Francisco, California 94122, United States
  • UPMC
    Pittsburgh, Pennsylvania 15213, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00829517
Lead sponsor
University of Pittsburgh
Responsible party
Eleanor Bimla Schwarz (Associate Professor of Medicine, University of Pittsburgh) — Principal investigator
First posted
Jan 27, 2009
Start date
Jan 2011
Primary completion
Nov 2011
Completion
Nov 2011
Last update
Feb 17, 2012

Study contacts

Eleanor B Schwarz, MD, MS
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion